Year: 2023

Posted on

Why healthcare leaders should embrace home-based technologies

Why healthcare leaders should embrace home-based technologies

Dwelling wellbeing technologies will have an significantly greater purpose to participate in in health care shipping as the silver tsunami of the getting older inhabitants strain the system. And if far more buyers embrace preventative treatment that can conveniently be finished in the house.

It really is crucial to comprehend that property well being technologies are leveraged in house wellness options by clinicians for residence overall health individuals, and at-residence or property-primarily based wellbeing technologies are diagnostic and/or screening tools that can be used in non-clinical settings for the reason of knowing in general wellbeing situations.

Household-based mostly wellbeing systems are any preventive care technologies tool that elevates wellness. This contains equipment like blood strain cuffs, excess weight scales, thermometers and other screening tools that can be used to gauge a biometric worth.

It also consists of equipment these kinds of as telehealth platforms that aid interaction between medical professionals and clients, smartwatches that observe heart charge, and other technologies used to deal with serious disease these kinds of as respirators and CPAP gadgets or other remote checking gadgets. In the previous, a lot of of these improvements ended up limited in protection and use to Medicare seniors.

Now they’re utilised a lot more broadly. One huge reason for this is the availability of wise capabilities this sort of as Bluetooth enablement (for case in point, Bluetooth-enabled digital scales or a digital glucometer that can evaluate overall cholesterol, glucose and triglycerides, and transmit this information and facts into a personal well being history).

“The greater benefit in smarter applications is that they can notify the individual or their doctor to potential health and fitness problems,” stated Travis Rush, CEO of Reperio, a vendor of at-house biometric screening systems. “One of the most obvious and tangible examples of this is know-how that detects elevated blood-glucose levels, a pink flag for prediabetes or diabetes.

“Considering the fact that a single in 4 youthful older people have diabetic issues but do not know it until eventually they stop up in the medical center in an unexpected emergency, owning this sort of capacity inside a resource is incredible,” he continued. “Also, since hospitals are usually so quick-staffed, they sometimes can’t take clients ideal away.”

Health care IT News sat down with Rush for a discussion of these house wellbeing concerns and technologies.

Q. You counsel healthcare provider firm leaders want to rethink healthcare shipping and delivery for 2023 by searching at household well being know-how advancements. Why?

A. The de-facto health care shipping program that we rely on these days is predicated on outdated norms and assumptions. For example, just for the reason that just about every particular person with insurance policies is made available an yearly wellness test as portion of their benefits does not signify that each individual individual usually takes gain of that providing.

In point, fewer men and women than ever stop by their primary care health practitioner on a standard basis – even if they have insurance plan.

That could possibly not seem like a massive deal, but the reality is that lots of Americans are struggling with continual health and fitness problems that go unmanaged or undetected. Present-day experiments counsel 60{08cd930984ace14b54ef017cfb82c397b10f0f7d5e03e6413ad93bb8e636217f} of People live with at the very least one persistent situation these types of as hypertension, which raises their possibility for sickness and preventable functions like heart attacks.

But even additional troubling, a lot of People are unaware of their overall health standing. For example, 96 million Us citizens are prediabetic, but 80{08cd930984ace14b54ef017cfb82c397b10f0f7d5e03e6413ad93bb8e636217f} do not know they have the condition.

Compounding this challenge is the doctor lack – Us residents are possessing a more difficult time securing an appointment with a physician than 10 a long time back. To no fault of our current and overworked healthcare workforce, a lot of patients are remaining in limbo although waiting around months for an appointment.

The ensuing inconvenience is foremost numerous seemingly healthful sufferers to skip an in-man or woman visit except if they’re experiencing bodily pain or noticeable indicators.

The confluence of all these trends is a phone to motion for all stakeholders. We require to reframe our collective state of mind all-around preventive treatment. We require to embrace hybrid approaches to healthcare that profit both of those clients and providers, this kind of as a change to telehealth for pre-operative consultations, or by utilizing residence-centered well being screening systems as an different to classic, in-person treatment.

Wellness metrics derived from at-home wellbeing screenings allow stakeholders to acquire detailed insight into the all round well being and very well-being of their populace and proactively mitigate expensive serious health conditions.

In basic, concentrating on preventive care, alternatively than reactive treatment, is central to our bodily and economic survival. Chronic disorders cost the U.S. an approximated $3.7 trillion for each calendar year, like misplaced financial productiveness.

Q. What are a number of of the most significant advancements, and why are they vital?

Numerous illustrations appear to head below.

One particular of the biggest innovations in household-centered systems is the array of available mobile apps that any individual can obtain. The ideal kinds, these types of as bodyweight decline applications that help customers to “chat” with a health and fitness coach, are participating and powerful – and can be a important instrument for high-hazard individuals to take the measures they want to avert ailment.

In conditions of residence-dependent screenings, the potential to evaluate blood glucose and cholesterol in the house, and then course of action those people blood samples on the place with a glucometer, is amazing. When a doctor’s workplace can oversee a screening, outcomes usually acquire times or weeks to system.

The most highly developed at-house screenings can deliver success and tips in less than an hour. Owning actionable insights is significant to engage persons that may possibly or else be in the darkish about their well being standing.

Health challenges these kinds of as superior cholesterol or significant blood-glucose – two danger variables for far more significant conditions like coronary heart illness or diabetic issues – aren’t constantly clear. People could skip their annual wellness check out if they come to feel fine, because heading to an appointment or blood-draw lab is inconvenient. By empowering sufferers to do a examination when it’s convenient for them, they’re more likely to have interaction.

Bluetooth abilities also are a essential improvement for residence-dependent screening applications: Measuring information is good but measuring data that can be remotely transmitted to a hub wherever it can be processed and synthesized with other metrics (for case in point, baseline averages for height, body weight, blood sugar) and provide assessments and recommendations in real time is a subsequent-amount capacity.

Q. How can residence overall health know-how developments enable ease the pressure on EMS expert services?

A. Dwelling-centered screening resources can ease the strain on emergency expert services by elevating consciousness of wellness difficulties, this kind of as elevated blood sugar, large blood stress and being overweight. These all are controllable danger elements for emergent treatment that an individual may perhaps not be mindful of with no a screening.

When individuals develop into knowledgeable of their actual health and fitness threats, or burgeoning wellness challenges, it is frequently the wakeup connect with they have to have to get severe about enhancing their health. Perhaps they need to have to just take a closer look at their food plan or training regimen or probably their problem is critical adequate to warrant a discussion with their principal treatment health practitioner about other interventions.

We only need to have to search into our current earlier, in the initially fifty percent of 2020, when unexpected emergency rooms were being flooded, but extra than a single in 4 individuals missed their preventive care appointments, mostly due to the fact they did not want to threat exposure and illness.

Though that is understandable, the drop in preventive care likely may have led to the spike in significant, but preventable, ailments. For illustration, according to the American Association for Most cancers Study, in between March and December 2020, the U.S. noticed an 11 per cent enhance in individuals diagnosed with inoperable or metastatic cancer in contrast with the exact period of time in 2019.

With that in head, let’s reconsider a condition like diabetic issues. Research propose just one in four men and women really don’t know they have it. But if an personal undergoes a straightforward blood-glucose screening and is advised that their elevated blood sugar amounts imply they need further screening, that particular person is empowered with facts: They can make the choice to see their health care provider for even more steerage or overlook the facts.

Prospects are they’ll choose to act on it. This little piece of data can help you save that particular person from a person or additional emergent treatment encounters and ease the strain on overworked healthcare employees.

Q. How can residence wellness engineering developments assist corporations concentrate on proactive avoidance?

A. This is an crucial concern, as health care prices are growing speedy, and seemingly uncontrollably, in numerous parts of the country.

A single matter we should take into consideration is how to leverage higher tech when we’re not going through a overall health emergency. Impressive solutions we relied on through the peak of the pandemic – like home-based professional medical tools and telehealth.

In 2020, the pandemic forced healthcare leaders and companies to implement various property-primarily based improvements or instruments. Not all of them were winners, but we can’t lose that mentality of embracing systems to enhance healthcare and get rid of inequities that exist.

In the long run, residence-primarily based wellness systems can help organizations empower their staff to interact in preventive care, which can assistance them to keep away from the larger fees of treatment down the line. It is no secret that serious wellbeing troubles, such as preventable problems this sort of as Sort 2 diabetic issues, price tag corporations a fortune, between productiveness losses and absenteeism.

Encouraging patients to interact in, and increase, their possess health starts off with meeting them at their amount. Most persons want to boost their health, but they don’t want to use their paid time off for preventive treatment.

There is no evident immediate gain to them for getting that action if they experience fine. We can nudge patients in the correct way by giving resources that are easy and easy to engage with.

By arming our workers with the equipment they have to have and want to protect against illness, we’re also demonstrating that we care about their well being, and want to protect against disease.

Adhere to Bill’s Hit protection on LinkedIn: Monthly bill Siwicki
E-mail the author: bsiwicki@himss.org
Healthcare IT Information is a HIMSS Media publication.

Posted on

Mental health crisis response program B-Heard adopted by several US cities sends EMTs, social workers instead of police officers

Mental health crisis response program B-Heard adopted by several US cities sends EMTs, social workers instead of police officers

NEW YORK Metropolis (WABC) — Some cities together with New York are screening out a pilot application that sends groups of EMTs and social workers to mental wellness emergencies rather of police officers.

The plan is referred to as B-Read, the behavioral health crisis aid reaction division that started in New York Town in 2021.

“This is a wellness look at,” FDNY EMT Isha Middleton explained. “We’re not right here to drag you away. When people see law enforcement they have a perception of them. And when we arrive, they see EMTs, fire department, they say hmmm. Now that window is open up and we have a prospect to go as a result of it.”

911 dispatchers send EMTs and social staff instead of law enforcement officers to take care of nonviolent psychological well being emergencies with the hope that the outcome is a peaceful final result.

“This is a way of bringing care into the crisis,” social employee Salley May possibly explained. “You see it in the second. You say, wow, this is different, you know, and you come to feel it.”

This is a crisis response staff not like any other in the metropolis gearing up to strike the streets of New York.

“It’s something the town genuinely wanted and it is really a thing that never ever existed in advance of,” FDNY Deputy Main Cheryl Middleton stated. “The possibilities were pretty confined. You know, NYPD would clearly show up and the individual would most frequently finish up in the crisis section.”

Individuals quite persons often enter the healthcare facility in handcuffs, shot, or killed.

People today with untreated mental health issues are 16 occasions additional probable to be killed by regulation enforcement, according to a report carried out by the Treatment method Advocacy Middle.

In Texas, Patrick Warren Junior states he termed 911 asking for a mental overall health checkup of his father, then his dad was shot and killed by police correct in entrance of him.

And in California, the relatives of Angelo Quinto suggests he was depressed and obtaining a psychological well being episode and died times right after an officer allegedly set a knee on his neck, which police deny.

Deaths involving regulation enforcement like these, have sparked calls for reform throughout the nation.

Cities like Portland, Oregon and Denver, Colorado are just two of a lot of that now have de-escalation courses in spot.

And though quite a few say this is a phase in the correct path, some others are contacting for much more development

Psychological overall health advocate Jordyn Rosenthal would like to see B-Read groups consist of so-termed friends, all those with their personal mental health and fitness diagnosis or encounter with a psychological well being crisis.

“They want to be there for the reason that they know what it truly is like to be the human being acquiring a disaster,” Rosenthal explained.

Appropriate now only about 22{08cd930984ace14b54ef017cfb82c397b10f0f7d5e03e6413ad93bb8e636217f} of psychological health and fitness 911 phone calls are at the moment staying routed to B-Listened to.

Rosenthal claims it’s not adequate.

“We have an oversaturation of phone calls that are currently being directed to police,” Rosenthal explained.

But Jason Hansman the Deputy Director of Psychological Wellbeing Initiatives in New York Town says progress would not materialize overnight.

“About a yr and a 50 percent in the past, we have been however sending cops and EMTs to each psychological health phone in the city,” Hansman mentioned. “We’ve modified that where, you know, we are responding to about a quarter of the phone calls. And this is a little something that is heading to acquire time.”

ALSO Browse | Observe Operation 7: Help save a Life, 25th anniversary edition

Copyright © 2023 WABC-Tv set. All Rights Reserved.

Posted on

NIH trial to evaluate Shionogi antiviral in adults hospitalized with COVID-19

NIH trial to evaluate Shionogi antiviral in adults hospitalized with COVID-19

News Launch

Wednesday, February 15, 2023

&#13
Trial protocol may be tailored to appraise further therapeutics.

The Nationwide Institutes of Wellbeing has initiated a multi-web site medical demo assessing an investigational antiviral for the treatment of COVID-19. The therapeutic, known as S-217622 or ensitrelvir fumaric acid, was identified by Hokkaido University, Sapporo, Japan and Shionogi & Co., Ltd., Osaka, Japan. The trial is evaluating no matter whether S-217622 can strengthen clinical results for sufferers who are hospitalized for administration of COVID-19 as when compared to a placebo and will enroll approximately 1,500 folks at internet sites throughout the world. S-217622 is the 1st agent to be evaluated in a new world wide, adaptive scientific study protocol recognized as Procedures and Treatment plans for Respiratory Bacterial infections & Viral Emergencies (Attempt).

The Countrywide Institute of Allergy and Infectious Conditions (NIAID), aspect of NIH, is funding the trial and performing in partnership with NIH’s National Middle for Advancing Translational Sciences (NCATS). Formulated less than the auspices of the NIH Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) community-personal partnership, Try may well be tailored to speedily assess many therapeutic interventions for the duration of outbreaks of respiratory illnesses, these kinds of as COVID-19 or influenza.

“We hope results from this demo can be used to enhance the conventional of treatment for individuals with COVID-19, which however results in hundreds of deaths every single day in the United States, as nicely as to bolster our pandemic preparedness,” stated NIAID Deputy Director for Clinical Exploration and Specific Projects H. Clifford Lane, M.D. “The Attempt protocol and scientific investigation infrastructure can be adapted to evaluate additional agents for COVID-19, as very well as therapeutics for other respiratory pathogens.”

Results from the ACTIV-3 trials, which evaluated therapeutics for grownups hospitalized with COVID-19, indicated that ongoing viral replication may engage in a position in driving illness progression to vital disease. The exploration group hypothesized that a major range of individuals hospitalized with COVID-19 might nonetheless gain from antiviral therapy.

S-217622 suppresses SARS-CoV-2 replication by inhibiting the perform of a crucial virus protein recognised as 3CL protease. The antiviral lessened COVID-19 symptoms in men and women with moderate-to-average COVID-19, regardless of possibility variables or vaccination position, in accordance to effects shared by Shionogi from a Section 3 scientific demo done mostly in Japan. S-217622 was well-tolerated, and there had been no remedy-similar really serious adverse situations or deaths in the research. In November 2022, the drug gained unexpected emergency regulatory approval in Japan, where it is referred to by the manufacturer identify Xocova. The ongoing ACTIV-2 SCORPIO-HR scientific trial, also funded by NIAID, is evaluating the antiviral in the outpatient populace.

Jason Baker, M.D., chief of infectious health conditions at Hennepin Healthcare and associate professor of drugs at the University of Minnesota, Minneapolis, is serving as trial chair. Demo co-chairs include things like Marcelo Losso, M.D., principal investigator at Hospital J.M. Ramos Mejia in Buenos Aires, Argentina, and director of Latin The us Coordination of Educational Scientific Investigate, Buenos Aires and Shikha Vasudeva, M.D., assistant professor of medication, Virginia Tech Carilion School of Medication, Roanoke, and infectious condition specialist, Department of Veterans Affairs Healthcare Heart, Salem, Virginia.

Contributors will be assigned at random to receive S-217622 or a placebo. Neither the investigators nor the participants will know who is obtaining the investigational drug. S-217622 is taken by mouth at the time day by day for 5 days. The to start with-day dose is 3 125 milligram (mg) tablets totaling 375 mg, followed by one 125 mg pill for every working day for the future four days. All members will obtain the regional typical of care for COVID-19, which may well vary primarily based on locale, and could incorporate another antiviral, as perfectly as immunomodulatory medicine, corticosteroids and/or anticoagulants.

Investigators will monitor and document participants’ overall health position each working day throughout the initially week and then on prespecified times above a 60-working day period. Individuals also will be questioned to offer blood samples and nose swabs for laboratory checks.

The examine team will perform analyses to have an understanding of any statistically important differences—meaning those not likely thanks to chance—between the therapy team and the placebo group. The vital metric they will concentration on is no matter if people obtaining S-217622 get better (outlined as returning residence and remaining alive by way of working day 60) more speedily than these in the placebo group.

Participant safety will be monitored closely all through the demo. An NIAID Professional medical Keep track of will overview any probable protection difficulties in real time, and an independent data and protection monitoring board (DSMB) will assessment security and efficacy details regularly.

The pace of enrollment and, eventually, the amount of money of time it can take to full the trial will depend on the trajectory of COVID-19 situations in several sections of the entire world. For extra information about the trial, you should check out clinicaltrials.gov and research identifier NCT05605093.

Attempt is aspect of the NIH ACTIV public-personal-partnership, which was initiated in April 2020 to create a coordinated exploration tactic for prioritizing and rushing development of the most promising treatments and vaccines for COVID-19. Attempt builds on the efforts of prior ACTIV grasp protocols that evaluated many therapeutics for individuals hospitalized with COVID-19. The Attempt Scientific Committee, chaired by Professor Jens Lundgren, M.D., from the College of Copenhagen, is composed of scientific trial gurus from numerous health-related specialties which includes infectious disorders, pulmonology, intense treatment, and emergency medicine. Try is also overseen by a leadership committee and a local community advisory board.

The Statistical and Facts Administration Center at College of Minnesota, led by James Neaton, Ph.D., is running Attempt in collaboration with eight intercontinental coordinating centers, bringing collectively former sites from the ACTIV-1, ACTIV-3, and ACTIV-5 scientific trials. In all, Strive can enroll individuals at much more than 200 sites on all 6 inhabited continents.

NIAID conducts and supports research—at NIH, during the United States, and worldwide—to review the will cause of infectious and immune-mediated illnesses, and to develop better means of avoiding, diagnosing and managing these illnesses. News releases, fact sheets and other NIAID-relevant resources are obtainable on the NIAID web site.

About the Countrywide Institutes of Overall health (NIH):&#13
NIH, the nation’s professional medical analysis company, consists of 27 Institutes and Facilities and is a element of the U.S. Department of Wellness and Human Expert services. NIH is the primary federal agency conducting and supporting simple, scientific, and translational healthcare research, and is investigating the results in, solutions, and cures for each frequent and rare disorders. For a lot more info about NIH and its packages, take a look at www.nih.gov.

NIH…Turning Discovery Into Well being®

###

Posted on

Why this transgender protester injected himself with testosterone in front of Florida officials

Why this transgender protester injected himself with testosterone in front of Florida officials

In a crowded general public conference space in Florida on 10 February, standing prior to the assembled customers of two point out clinical licencing boards, Lindsey Spero opened his jacket, lifted up his shirt, and injected himself with testosterone.

This was an totally program method for Spero, a 25-year-aged transgender youth employee in St Petersburg, Florida, who has been using testosterone to masculinise their overall body since June 2019.

But it was pretty much surely a initially for Florida’s Board of Drugs and Board of Osteopathic Medicine, which are in the approach of pushing by means of a controversial statewide ban on prescribing such solutions to trans people today under 18.

“There was a whole lot of silence, and about three or four of them seemed away,” Spero explained to The Unbiased the working day just after the protest, which was broadcast live on the internet and speedily captured the imagination of trans men and women across the country.

Spero, who is non-binary and uses both of those masculine and gender-neutral pronouns, reported they desired to assist normalise the procedure in the eyes of cisgender (or non-trans) men and women and inspire other people to just take motion versus what he described as a “targeted assault” on trans persons in the Sunshine Point out.

“I wished the Board to see and be pressured to bear witness, mainly because I could convey to they are the form of men and women that would be uncomfortable with a thing like that, for the reason that people are typically fearful and uncomfortable with something they will not have an understanding of,” Spero reported.

“But even a lot more, I did want it to be something that would motivate our trans siblings… an injection can be a actually overwhelming regime issue to have to take part in, and it is even more scary to know how critical it is and even now have people today fundamentally gaslighting you over the requirement of your medication, regardless of you conquering all the limitations to be ready to get it.

“This was one particular significant aged ‘f*** you’ to all of that, and a declaration of the necessity and the sacredness of this medication for myself and my entire body.”

‘We require to consider action, even when it is scary’

The professional medical boards’ rule changes are section of a sustained campaign by Florida Governor Ron DeSantis to limit trans teenagers’ accessibility to transition healthcare.

The state’s Division of Health and fitness asked the Board of Medication previous calendar year to ban doctors from prescribing puberty blockers, hormone substitute treatment (HRT), or surgical procedure to new trans sufferers beneath-18.

The plan enables trans minors already going through a presented remedy to go on finding it, and does not use to cis minors approved the exact same treatment plans for circumstances this sort of as precocious puberty.

Nevertheless although these treatment options are broadly endorsed for trans youngsters by nationwide and global health care organisations, the Board of Drugs – whose members are straight appointed by the governor for four-yr phrases – accepted the proposal.

Mr DeSantis and his supporters argue that underneath-18s are not able to definitely consent to these types of strategies, pointing to the relative paucity of extended-time period investigation into their results and touting testimony from a minority of people today who regret the therapies. The governor has consistently referred to sexual intercourse reassignment surgical procedure, which is scarce for underneath-18s, as “genital mutilation”.

“Today’s vote will shield our kids from irreversible surgical procedures and highly experimental treatment options,” claimed Florida’s surgeon standard Joseph Ladapo past November. “Young children deserve to discover how to navigate this world with no damaging tension, and Florida will carry on to combat for children to be children.”

Spero did not count on any change to arrive from Friday’s conference, which was held to listen to community feedback and allow the Board of Osteopathic Medication to deliver their personal policy into line with the Board of Health’s. Even so, he drove 4 hours to the condition money of Tallahassee to make their statement.

“I came to the summary that I could give them all the logic and cause in the planet,” Spero tells The Impartial. “I could offer that Board of Medicine just about every sympathetic story, each and every tear-jerking reaction, I can set my heart on full show, I can call them out for their lack of knowledge.

“None of these methods feel to have been successful or changed their views in any way… it just seemed like a strong way to clearly show them that we would be inclined to do much more than just stand at that podium and discuss… we are heading to have to take action, even when it truly is hard and even when it’s scary.”

In fact, the Board appeared unmoved by one more speaker, trans 12-year-aged Lola Smith, who said: “The most uncomfortable instant of my existence is going on suitable now as I stand in front of a panel of strangers and publicly beg for my ideal to exist. Almost nothing is extra humiliating and dehumanising than pleading for one’s individual existence.”

Major up to their protest, Spero was “fairly anxious” and well prepared to likely be kicked out of the home or even arrested and charged with a crime. But once they stood up, they say they felt “prevail over” with calmness drawn from the courage of other trans persons, residing and useless. “It felt like some thing else arrived over me totally,” they increase.

Draped in a trans pleasure flag, Spero informed the officials that he had tried suicide in the past mainly because he could not accessibility changeover health care, and accused them of “sneering” and not listening when trans speakers “put their hearts on whole exhibit”.

“My treatment is everyday living-conserving. I will use HRT for the relaxation of my life,” Spero explained. “Your denial of my want for this medication will not make my existence as a trans particular person any considerably less true.”

The Board of Medication was not swayed, and the Board of Osteopathic Drugs voted unanimously to get rid of an exemption for trans minors enrolled in analysis programmes at point out universities, bringing the two bodies’ policies into line.

“I’m sorry it’s awkward. We’re in an unpleasant problem,” stated Board of Medicine member Dr Hector Vila, according to the South Florida Sunlight-Sentinel. “I come to feel like there is a great deal of the general public thinks I dislike them. Not at all. We simply cannot even make a sincere remark, and it is hurtful to us.”

Immediately after the vote, Spero states board members they still left the home, leading to the audience – who mostly opposed the new rule – to stand up and start off chanting trans legal rights slogans.

The video clip was then posted on Twitter by civil rights attorney Alejandra Caraballo, activist Erin Reed, and some others, spreading greatly among the trans men and women on the social community.

Trans teenagers already staying slice off from cure

Beyond in search of to ban transition treatment for minors, Mr DeSantis has sought to cease educational institutions teaching little ones about trans challenges, focused all-ages drag displays and moms and dads who deliver little ones to them, and asked for facts from point out universities on how numerous persons they experienced offered trans healthcare to.

In the meantime, Republicans in many states have proposed equivalent health care bans, as effectively as bans on trans folks competing in college sports as their preferred genders. In some spots, this kind of as Texas, they have sought to determine trans healthcare for minors as little one abuse.

For the reason that Spero operates with younger trans people in Florida, they are acutely aware of what outcome the Board’s rule variations – and a common weather of developing “vitriol” – are already getting.

“Sad to say I am observing this influence every single day,” they say. “I experienced a few distinct youths who dropped access to gender-affirming treatment for the reason that community organisations have been fearing fallout as a end result of the professional medical board making this language, and so they prematurely resolved to take away obtain for any person less than the age of 18.”

He claims the distress caused by owning clinical care cut off – forcing patients to stay with powerful inner thoughts of despair and discomfort with their entire body as they undergo the mistaken puberty – is most likely to lead to “an uptick in suicide”, building this a “everyday living and death” situation that he has “no choice” but to oppose.

Spero appreciates about that initially-hand because, they say, they are a survivor of conversion treatment. They grew up in an “extremely conservative evangelical atmosphere” and were despatched to a number of programmes and services intended to suppress their sexuality and gender identity, which they explain as “a sort of torture”.

Despite this, Spero considers staying trans a “holy” encounter. In his speech he referred to his testosterone shot as “a sacred and weekly ritual”, and he tells The Unbiased he is “however a pastor’s child”.

“Becoming trans is holy for the reason that we exist to mend the broken sections of culture,” they say. “The divides that exist, the binaries that have been created, the constructions all close to us that divide us as human beings…

“My shot has hardly ever just been my shot it is staying performed with the hands of my trancestors” – this means other trans people who went prior to them – “and for the trans youth who have to have access and who are going to require access in the long term.”

Posted on

The Top 25 Women Leaders in Medical Devices of 2023

The Top 25 Women Leaders in Medical Devices of 2023

The Healthcare Technology Report is pleased to announce The Top 25 Women Leaders in Medical Devices of 2023. Technology is advancing at a rapid pace across industries, and perhaps nowhere is that more true than in the medical device market. In fact, according to Fortune Business Insights, the global market is projected to grow from roughly $495 billion in 2022 to nearly $719 billion by 2029 at a CAGR of 5.5{08cd930984ace14b54ef017cfb82c397b10f0f7d5e03e6413ad93bb8e636217f}. There is intense competition in the market, and the women on this year’s list and the companies they represent have found success innovating across a range of specialties, from insulin management systems to regenerative technologies, electrotherapy, and wireless surgical solutions.

Some of the distinguished leaders on this year’s list include Tania Saison, SVP and CCO/CRO of Edwards Lifesciences, who oversees the company’s Global Integrity Program, which establishes a comprehensive framework for ensuring compliance with applicable laws, regulations, and standards of conduct. Meanwhile, Jennifer Ernst, CEO of Tivic Health, built her company from founding to IPO in 5 years and put an award-winning medical device into market within 3 years. And Manisha Shah-Bugaj, COO of Activ Surgical, oversees the ongoing development and commercialization of the company’s products, including ActivSight™ Intelligent Light, which aims to provide enhanced visualization and real-time, on-demand surgical insights in the operating room.

The awardees on this year’s list lead from a range of positions, from President and CEO to SVP, EVP, and COO. What they have in common is their dedication to innovation in the medical device space, bringing revolutionary new devices to market and improving the lives of patients and clinicians alike. Please join us in celebrating The Top 25 Women Leaders in Medical Devices of 2023.

 

1. Tania Saison
Company: Edwards Lifesciences
Title: Senior Vice President and Chief Compliance Officer/Chief Responsibility Officer

Tania Saison is Senior Vice President and Chief Compliance Officer/Chief Responsibility Officer for Edwards Life Sciences, the global leader in patient-focused medical innovations for structural heart disease, as well as critical care and surgical monitoring. As CRO, Saison oversees the company’s Global Integrity Program with unwavering support from the Board of Directors and executive leadership. The program establishes a comprehensive framework for ensuring compliance with applicable laws, regulations, and standards of conduct, and reinforces Edwards’ culture of integrity and ethics. Saison is a member of the global senior leadership team.

Prior to Edwards, Saison served as VP and Chief Compliance Officer for Agilent Technologies. She got her start at Agilent as Senior Compliance Counsel. Previously, she was Assistant General Counsel and Head of Global Compliance for Beckman Coulter, Senior Counsel for Diageo plc, and served as an attorney for Hunton & Williams and Dewey Ballantine LLP. Saison earned her JD from Columbia Law School, her MBA from Harvard Business School, and her Bachelor of Arts in history from Columbia University.

 

2. Simona Serban
Company: Fresenius Medical Care
Title: Chief Operating Officer

Simona Serban is based in Bucharest, Romania. She currently serves as the Chief Operating Officer of Fresenius Medical Care, the world’s leading provider of products and services for individuals with kidney diseases. Fresenius aims to create a future worth living for chronically and critically ill patients — worldwide and every day. Thanks to the company’s decades of experience in dialysis, its innovative research, and its value-based care approach, it is helping patients enjoy the very best quality of life.

Prior to her COO role, Serban held assignments of increasing responsibility in the healthcare industry. This includes stints serving as a customer solutions manager and sales representative for Merck Sharp & Dohme Romania SRL. Her areas of expertise include pharmaceutical sales, product launch, market analysis, marketing management, and hospital sales, among others. She holds a degree from the Universitatea Alexandru Ioan Cuza, which is located in Iasi, Romania.

 

3. Aviva McPherron
Company: NuVasive
Title: Chief Information Officer and Senior Vice President of IT

Aviva McPherron serves as NuVasive’s Chief Information Officer and Senior Vice President of IT, and is responsible for the company’s information technology organization. NuVasive is committed to transforming surgery, advancing care, and changing lives through less invasive, procedurally integrated solutions. Since its inception in 1999, it has continually outperformed the market as the largest, spine-focused company in the world. With more than $1 billion in revenues, NuVasive has approximately 2,600 employees and operates in more than 50 countries serving surgeons, hospitals and patients.

McPherron’s previous roles include VP of Enterprise Applications and Senior Director of Business Solutions. Before joining NuVasive, she was Director of Operations for Tapestry Solutions, a Boeing Company, and has held multiple technical leadership positions delivering transformative solutions. McPherron holds a Bachelor of Science in mechanical engineering from Stanford University.

 

4. Elizabeth Sebern McCombs
Company: BD
Title: Executive Vice President and Chief Technology Officer

Elizabeth Sebern McCombs serves as Executive Vice President and Chief Technology Officer of BD (Becton, Dickinson and Company), a leading global medical technology company headquartered in Franklin Lakes, New Jersey. In this role, she is responsible for leading all R&D activities for BD, advancing new product innovation and development from early-stage concepts through launch, and sustaining the current product portfolio. She is also a member of the BD Executive Leadership Team.

McCombs joined BD in 2019 as the Senior Vice President, R&D for the BD Medical Segment, where she co-led the segment portfolio strategy and growth acceleration initiatives. Prior to joining BD, she spent more than 20 years at Johnson & Johnson (J&J), most recently as Vice President, R&D for Ethicon, J&J’s surgical device franchise. Aside from her technical credentials, McCombs has been recognized for her work driving inclusion and diversity efforts, including the support and mentorship of fellow female professionals. She holds an MBA from the University of Pennsylvania’s Wharton School of Business and both a Master of Science and Bachelor of Science in mechanical engineering from the Massachusetts Institute of Technology.

 

5. Niamh Pellegrini
Company: Nevro
Title: Chief Commercial Officer

Niamh Pellegrini currently serves as Chief Commercial Officer for Nevro, a global medical device company focused on delivering innovation to improve the quality of life for patients suffering from debilitating chronic pain. Pellegrini is a proven commercial leader with over 30 years of experience in the healthcare industry. Prior to joining Nevro, she was Vice President of Global Commercial Operations for Abbott Vascular.

Before Abbott, Pellegrini served as CEO and President at Autonomic Technologies, Inc. and President, North America at Thoratec Corporation. Prior to Thoratec, she served in progressively responsible global business development, strategy, and commercial roles at Johnson & Johnson. Pellegrini currently serves on the Board of Directors of Acutus Medical. She graduated from Santa Clara University with an MBA and a Bachelor of Science in finance.

 

6. Lena Hagman
Company: XVIVO
Title: Chief Operating Officer

In December 2022, Lena Hagman was appointed Chief Operating Officer of XVIVO, the first global all organ company. Founded in 1998, XVIVO is the only medical technology company dedicated to extending the life of all major organs — so transplant teams around the world can save more lives. Hagman has extensive global operational experience within the medical device industry, and has for the last 12 years been in different executive roles within the Getinge group, a Swedish global MedTech company. Her most recent role was as Executive Vice President for Quality compliance, Regulatory and Medical Affairs, which she held for 7 years.

Throughout her career, Hagman has been active in the medical device industry, with more than 20 years in leading positions with global responsibilities in R&D, supply chain, and quality/regulatory/medical affairs. Over the years, she has led many strategic and efficiency programs and company integrations. She has deep knowledge and experience in different global medical device quality regulations and with a high customer and patient centricity focus. She holds a Bachelor of Science in chemistry and textile engineering from Chalmers University of Technology, Sweden and is based at XVIVO’s headquarters in Gothenburg.

 

7. Jennifer Ernst
Company: Tivic Health
Title: Co-Founder and Chief Executive Officer

Jennifer Ernst is the Co-Founder and Chief Executive Officer of Tivic Health, a commercial phase healthtech company focused on advancing bioelectronic medicine. Ernst has more than 20 years of experience in the commercialization of breakthrough innovation and a history of developing markets from frontier technologies. As CEO of the U.S. subsidiary of Thin Film Electronics, she helped build the company from eight to 130 people, achieved a $480 million market cap in five years, and launched international award-winning products.

Ernst has held positions at Xerox PARC, positioning research for productization through strategic partnerships and licensing, and served as chairperson of Flex, the U.S. National Consortium for Flexible and Printed Electronics, now part of SEMI. She participated in the launch of the Global Women’s Leadership Network and was named to the Inc. Female Founders 100 and to the Healthcare Technology Report Top Women Leaders in Consumer Healthtech. She received an MBA from Santa Clara University and a Bachelor of Arts from San Francisco State University.

 

8. Manisha Shah-Bugaj
Company: Activ Surgical
Title: Chief Operating Officer

In December 2022, Manisha Shah-Bugaj was promoted from Activ Surgical’s Chief Operating Officer, a position she had held for just under a year, to its newest Chief Executive Officer. In addition to engaging with company partners, customers, and investors, Shah-Bugaj oversees the ongoing development and commercialization of Activ Surgical products, including ActivSight™ Intelligent Light, which aims to provide enhanced visualization and real-time, on-demand surgical insights in the operating room.

Prior to joining Activ Surgical, Shah-Bugaj architected the gynecology unit at Olympus from the ground up in the U.S., ultimately serving as General Manager and Global Vice President for the company, and played an integral role in expanding the gynecology business internationally. She has more than two decades of experience, including building and implementing corporate business plans, directing regional and global businesses aligned to financial and operational targets, hiring and establishing new teams, and managing product portfolios. She holds a Master of Engineering Management and a Bachelor of Engineering in biomedical engineering, both from Dartmouth College.

 

9. Anna Lucsok
Company: Zynex Medical
Title: Chief Operating Officer

Anna Lucsok currently serves as Chief Operating Officer for Zynex Medical. Zynex, founded in 1996, markets and sells its own design of electrotherapy medical devices used for pain management and rehabilitation. The company’s proprietary NeuroMove device is designed to help the recovery of stroke and spinal cord injury patients. Zynex has also developed a blood volume monitor for use in hospitals and surgery centers.

Previously, Lucsok served as Vice President of Reimbursement and Sales Operations with Zynex. In this position, she was responsible for leading and expanding Zynex’s order, reimbursement, patient experience, and inside sales support operations. During her tenure, each of these teams consistently achieved quarterly targets, while also expanding in size. Lucsok brings more than nine years of healthcare operations experience as well as critical knowledge of revenue cycle management and medical care collections. She has been involved in various operations positions as well as management positions with Zynex since her start in 2018, including serving as Billing Manager. She previously held key positions with companies such as the University of Colorado Hospital, the U.S. Air Force based in Germany and Japan, and Schryver Medical. Lucsok holds certification in medical billing and earned her Bachelor of Science in healthcare administration and management from Colorado State University.

 

10. Sreelakshmi Kolli
Company: Align Technology
Title: Executive Vice President, Chief Digital Officer

Sreelakshmi Kolli is Executive Vice President Chief Digital Officer for Align Technology. She is responsible for leading software, data, enterprise, cloud, and infrastructure engineering teams focused on the design and development of digital products and services. This includes defining the technology strategy and development of product software, consumer, customer, manufacturing, and enterprise applications enabling the Align Digital Platform. In addition, Kolli led Align’s global business transformation initiative aimed at delivering platforms and technology to support customer experience and simplified business processes across the company.

Kolli joined Align in June 2003 as Manager, Software Engineering and held positions of increasing responsibility leading business operations and engineering for customer-facing applications. She was promoted to Senior Vice President, Global IT in December 2012 before being promoted to her current position in April 2020. Prior to joining Align, Kolli held technical lead positions with Citadon and Accenture. She is also a member of the Board of Directors at Zimmer Biomet Holdings, Inc. Kolli earned a Master of Science in computer applications at the National Institute of Technology in Trichy, India and is a graduate of the Stanford Executive Program offered by the Stanford Graduate School of Business.

 

12. Deborah Gordon
Company: Insulet
Title: Vice President, Investor Relations

Deborah Gordon has served as Vice President, Investor Relations for Insulet Corporation since January 2015. Insulet is a roughly $1 billion medical device company dedicated to making the lives of people with diabetes easier through its OmniPod Insulin Management System. Gordon also serves on the Board of Directors of the L.S. Starrett Company, serving on the Audit Committee since July 2020 and the Compensation Committee since July 2021.

Prior to joining Insulet, Gordon served in a number of roles of increasing responsibility during her 10 years at Hologic, Inc. and Cytyc Corporation (which merged with Hologic in October 2007). Notably, she served for seven years as Hologic’s Vice President, Investor Relations and Corporate Communications and prior as Assistant Corporate Controller and Director of SEC Reporting and Technical Accounting at Cytyc. Before joining Cytyc, Gordon served in the audit practice at Deloitte & Touche for 11 years. She earned her Bachelor of Arts in business administration, with concentrations in accounting and economics, from Clark University and is a certified public accountant.

 

13. Suzanne Winter
Company: Accuray
Title: President and Chief Executive Officer

Since July 2021, Suzanne Winter has served as President of California-based medical equipment manufacturer Accuray, and in July 2022 she was promoted to Chief Executive Officer as well. In her position at the head of the company, Winter has continually driven the expansion of Accuray’s radiotherapy cancer treatment technologies, yielding record order volume and the approval of numerous novel treatments in China and beyond. She has had a significant impact on Accuray’s product portfolio and commercial momentum since joining the company.

Prior to joining Accuray, Winter held senior executive roles spanning general management, commercial operations, and business development across a range of healthcare industry segments, including radiology, neurology, and surgery. Most recently, she served as Group Vice President – Americas region at Medtronic Diabetes, where she was responsible for leading the 2,000 person commercial organization. Before Medtronic, Winter was the General Manager of GE Healthcare’s Detection and Guidance Solutions operations. She earned an MBA from Harvard Business School and a Bachelor of Science in chemistry from Saint Lawrence University.

 

14. Sandra Hirsch
Company: Zyris, Inc.
Title: President and Chief Executive Officer

Sandra Hirsch is the third founding member of Zyris, Inc., pairing decades of experience as a financial manager and CPA with a zeal for entrepreneurship sparked by her Bachelor of Science in business administration from the University of Southern California. Under her leadership as President and Chief Executive Officer, Zyris has grown from a struggling start-up to the world leader in dental isolation, distributing Isolite products throughout North America and in more than 20 countries overseas. Hirsch is defined by her family, the Zyris team, and unwavering resolve to forever change the experience of dentistry for patients and clinicians.

In 2001, Hirsch founded Innerlite Inc. with her husband Jim Hirsch, an industrial designer, and her brother-in-law Tom Hirsch, a practicing dentist. Together, they rebranded the company as Isolite Systems and launched their flagship product, the Isolite illuminated dental isolation system, in 2002. Isolite enables dental practices of all sizes to implement a technique for controlling the oral environment, providing an innovative solution for dental isolation. Offering a full line of isolation products that are minimally invasive and easy-to-use, Isolite Systems allows dental professionals to work more productively and effectively with less stress and fatigue for both themselves and their patients.

Today, Hirsch serves as President and CEO of Isolite Systems. Under her leadership, the company has grown from a single game-changing idea to an international phenomenon, with over fifty employees at their Santa Barbara-based manufacturing and distribution center and representatives worldwide. Thousands of dentists in over twenty countries are loyal fans of the safety, comfort, and control that Isolite dental isolation provides. In the U.S., over 20{08cd930984ace14b54ef017cfb82c397b10f0f7d5e03e6413ad93bb8e636217f} of all dental schools have adopted their products, which will soon become the standard of care for everyday dental procedures. Hirsch and the Isolite team continue to develop products that make a difference in people’s lives. They are relentlessly focused on the pursuit of a better dental experience for every patient and have earned numerous awards and accolades for their efforts.

 

15. Tavia Walsh
Company: Pulse Technologies
Title: Co-Founder Chief Technology Officer

Tavia Walsh is a Co-Founder and the Chief Technology Officer of Pulse Technologies, an entrepreneurial startup based in Vancouver designing innovative, low-cost consumer wearable devices using emerging new conductive materials and 3D printing methods. As a biomedical engineer with both an electrical and mechanical background, Walsh has an interest in complex problem solving and design thinking; and as a founder of Pulse, she has experience in the biomedical start-up space.

Walsh co-founded Pulse Technologies in 2016. While working on Pulse, she served as a biomedical engineer for 4M BioTech from 2020-2021 and as a mechanical engineer for ViVitro Labs Inc. from 2021-2022. Walsh earned her MD from University College Dublin, her Master of Applied Science in mechanical engineering from the University of Victoria, and her Bachelor of Applied Science from The University of British Columbia.

 

16. Jennifer Honeycutt
Company: Danaher
Title: Executive Vice President

As Executive Vice President, Jennifer Honeycutt provides strategic and operational leadership for Danaher’s Environmental and Applied Solutions businesses, which includes the Product Identification and Water Quality platforms. She also oversees Danaher’s High Growth Markets and regional teams outside of China. Honeycutt originally joined Danaher with the 2000 acquisition of Hach and has held positions of increasing responsibility across multiple industries over the past 20+ years.

Leadership roles at Hach Ultra Analytics, Anderson Instrument Company (now part of Fortive), Linx Printing Technologies, Beckman Coulter Life Sciences, and Pall have given her deep knowledge of the Danaher Business System (DBS) and a unique perspective on the many ways Danaher can help realize life’s potential across its businesses. Honeycutt is a champion of the power of diversity, and a longstanding member of Danaher’s Diversity + Inclusion Council. Throughout her tenure, she has consistently delivered strong results by building high-performing teams and driving strategic M&A, innovation, and commercial execution. Honeycutt earned a Master of Arts in Technology Management from the University of Denver and Bachelor of Arts degrees in chemistry and French from Grinnell College.

 

17. Pooja Pathak
Company: LumiraDx
Title: Chief Product Officer

Since June 2021, Pooja Pathak has served as Chief Product Officer for LumiraDx, a next-generation point of care diagnostics company based in the U.K. Founded in 2014, the company provides a comprehensive portfolio of testing solutions used by governments and leading healthcare institutions. Pathak, who previously served as LumiraDx’s Vice President of Platform Strategy, is currently responsible for product management, marketing, and medical affairs.

Prior to LumiraDx, Pathak most recently worked at Abbott as VP of Global Marketing for the Infectious Disease Emerging Markets business, which included 170 countries across Asia, EMEA, and Latin America. In this role she was responsible for a $500 million portfolio. Additionally, she has held leadership roles with Alere and Novartis Vaccines, where she focused on bringing new innovations to market, implementing integrated diagnostic and treatment programs, and rolling out global public health solutions. Pathak holds a Master of Science in chemical engineering from MIT and a Bachelor of Science in chemical engineering from the University of Illinois Chicago.

 

18. Kelli Howell
Company: Alphatec Spine
Title: Executive Vice President, Clinical Strategies

Kelli Howell has served as Executive Vice President, Clinical Strategies of Alphatec Spine since March 2018. Alphatec improves lives by providing innovative spine surgery solutions through its relentless pursuit of superior outcomes. The company is dedicated to the design, development, launch, and the delivery of spinal fusion products. Alphatec accomplishes this by working with spine surgeons to design and develop products and systems that address the entire spinal fusion procedure in the most effective and efficient way possible. Its product designs and platforms provide innovation through a focus on simplifying procedures for the surgeon with the ultimate objective of superior outcomes.

For the 18 years prior to joining Alphatec, Howell held various management positions at NuVasive, Inc., including Vice President, Research & Health Informatics from January 2017 to March 2018, Vice President, Research & Education from February 2015 to January 2017, and Vice President, Research from April 2012 to February 2015. Prior to joining NuVasive, Howell was involved in research at Orthopedic Biomechanics Laboratory (OBL), Beth Israel Deaconess Medical Center in Boston. Howell received a Master of Science in biomedical engineering from Boston University and a Bachelor of Arts in engineering sciences from Dartmouth College.

 

19. Alison Burdett
Company: The Surgical Company
Title: Chief Scientific Officer

Alison Burdett has over 30 years of experience in electronic engineering and semiconductor design, particularly in the field of ultra-low-power wireless communication for medical applications. She co-founded Toumaz in 2001 and served as the Technical Director. She became the Chief Technical Officer in 2006, responsible for delivering silicon and advanced technology programs for both consumer and healthcare divisions of the business. In 2016, the healthcare business unit of Toumaz, Sensium Healthcare, became part of The Surgical Company Group and she joined Sensium, where she became the Chief Scientific Officer, responsible for all engineering and scientific programs for the company’s digital health products.

Prior to joining Toumaz, Burdett spent time both in industry as an integrated circuit designer, and also in academia (as a Senior Lecturer of Analog IC Design with Imperial College London). She is a Visiting Researcher with the Institute of Biomedical Engineering, Imperial College. She has more than 80 peer-reviewed publications and is a named inventor on more than 20 patents. Burdett was a member of the Technical Programme Committee for the IEEE International Solid-State Circuits Conference (ISSCC) from 2009 to 2018, serving as the European Regional Chair 2012–2014 and the Technical Program Chair for ISSCC 2018. She has been an Associate Editor of IEEE Transactions on Biomedical Circuits and Systems since 2008, and is the Associate Editor-in-Chief of the IEEE Open Access Journal of Circuits and Systems. She is a Chartered Engineer and a Fellow of the Institute of Engineering and Technology. Burdett earned her PhD in analogue IC design and her bachelor’s degree in electrical and electronics engineering from Imperial College London.

 

20. Rhonda Robb
Company: Cardiovascular Systems, Inc.
Title: Chief Operating Officer

From January 2018 to June 2022, Rhonda Robb served as Chief Operating Officer of Minnesota-based medical device manufacturer Cardiovascular Systems, Inc., a medical device company developing and commercializing innovative interventional treatment systems for peripheral and coronary artery disease. In her time at the company, Robb was renowned for her agile, forward-thinking leadership style, and her efforts helped bring the company to numerous new patients and a greatly expanded product line.

In the time since her departure from Cardiovascular Systems, Robb has continued to serve on the board of 4C Medical Technologies. Robb formerly served as Vice President and General Manager of the Heart Valve Therapies business at Medtronic. In that role, she was responsible for the transcatheter and surgical valve franchises. Previously, Robb held additional leadership positions in Medtronic’s Coronary, Peripheral, and Cardiac Rhythm businesses. She has strong experience leading complex businesses, growing new markets, extensive commercial experience, and a strong track record of building teams and product portfolios that have improved the quality of care for patients with cardiovascular disease. Robb holds an MBA from the University of Minnesota’s Carlson School of Management.

 

21. Jessica Lynch
Company: DentalMonitoring
Title: Chief Operations Officer – North America

Since April 2022, Jessica Lynch has been Chief Operations Officer – North America at DentalMonitoring, the leading Intelligent Platform globally which provides connected, smarter and more sustainable dental care. DentalMonitoring creates with doctors and partners an environment to deliver the best dental care to patients, synchronized with their treatment needs. Showcasing a unique, people-first leadership style, Lynch has helped the company improve financial results while enjoying sustainable organizational growth. Recent achievements by DentalMonitoring have included new advances in AI-driven dental technologies and a unique new gamified feature in its signature platform.

Prior to DentalMonitoring, Lynch served as Vice President of Operations Excellence and Vice President of Strategy for Smile Doctors. Before that, she was Chief Operating Officer for DN Orthodontics for four years. She also served as Senior VP, Doctor Relations (2010-2014) and Director of Operation Consultants (2009-2010) for OrthoSynetics, and was a physician liaison for Louisiana Medical Center and Heart Hospital, LLC. Lynch holds a Bachelor of Science in business administration from the University of Louisiana at Lafayette.

 

22. Rebecca Lin
Company: Potrero Medical
Title: Chief Strategic Officer

With her unique blend of business acumen and technical expertise, Rebecca Lin is a dynamic leader with many years of success in the healthcare industry. Today she serves as the Chief Strategic Officer for Potrero Medical, a Hayward, California-based predictive health company developing the next generation of medical devices with smart sensors and artificial intelligence. Lin, who has been with the company since October 2016, previously served as the Senior Vice President of Sales and Marketing. In that role, she built and led the commercial organization that developed go-to-market strategies for Potrero’s Accuryn Monitoring System.

Over the years, Lin has achieved success at both large corporations and startups. Prior to her work at Potrero, she was the VP of Business Development at Theranova and led marketing initiatives for C. R. Bard (now owned by Becton Dickinson), in both Shanghai and the U.S. She has also worked as a Board Fellow at the American Red Cross Bay Area, currently serves as a guest lecturer at the University of California, San Francisco and Berkeley, and spent several years in sales and training at Johnson & Johnson. Lin holds a Master of Science in management from the Stanford University Graduate School of Business and a master’s in marine biology from Sun Yat-sen University in Guangdong, China.

 

23. Kristie West
Company: Orchid Orthopedic Solutions
Title: Chief Operating Officer

Kristie West is the Chief Operating Officer at Orchid Orthopedic Solutions, a global leader in medical device outsourcing services. Founded in 2005, the company’s 1,500 employees work to provide a broad array of capabilities in the world of orthopedic devices, including design, regulatory affairs, implant manufacturing, and instrument manufacturing, among other areas. West, who is a Six Sigma Black Belt and a Master Black Belt, joined Orchid in January 2022.

West came to Orchid from General Electric’s Edison Works Programs and Operations team, where she was the Senior Executive Director supporting the future of military combat and space. Prior to joining the Edison Works team, West was the Senior Executive for the Tubes & Ducts Value Stream in GE Aviation’s Supply Chain organization. She also held a number of leadership roles within GE, including Director of Operations for Unison Industries (a GE company); Executive Plant Leader for Avio Aero (a GE company), in Torino, Italy; Supply Chain Strategy Leader for GE Aviation; and CF6 Customer Programs Leader. Prior to GE, West held various leadership roles in manufacturing with Navistar and Carrier Global Corporation. She holds a Bachelor of Science in organizational leadership from Purdue University’s Polytechnic Institute.

 

24. Liz Hammack
Company: Pristine Surgical
Title: Chief Manufacturing Officer

Liz Hammack is Chief Manufacturing Officer of Pristine Surgical, a medical device company with a mission to simplify endoscopy. While Hammack joined the company in September 2021, her career began more than 30 years ago. During this time, she has worn many hats: from working on the factory floor, to holding multi-plant leadership, to operating in the boardroom. In addition to her work at Pristine, she is also the principal owner of Hammack Manufacturing Solutions, which is based in Portland, Oregon.

Prior to Pristine, Hammack spent 16 years at Medtronic, most recently serving as a Vice President of Manufacturing and Operations, AFS. In that position, she led operations, manufacturing, and supply chain integration activities for the newly formed AF Solutions business at Medtronic-CRDM. In 1981, she graduated from Oregon State University with a Bachelor of Science in industrial engineering. A proud alum, she has since served on numerous boards for the university’s College of Engineering. Furthermore, in 2013, she received Oregon State’s distinguished engineer award.

 

25. Dina Dubey
Company: Teleflex
Title: Chief Operating Officer

Dina Dubey is the Chief Operating Officer of Teleflex. Dubey’s roots with the company go back to 2011, when she started off as Director of Research and Development for Z-Medica, which was acquired by Teleflex in 2020. In this position, Dubey drove a pipeline of projects and developed and drove QuikClot Control+, the organization’s first-of-its-kind, new-generation hemostatic dressing, which ultimately resulted in commercialization of the product. On top of that, Dubey was a vital member of the executive leadership team that grew Z-Medica’s revenue from $28 million to $64.8 million.

Dubey started her career at Kensey Nash Corporation (now DSM Biomedical), where she spent eight years in engineering and management roles. In 2003, she received a Bachelor of Science in biomedical engineering from Case Western Reserve University. She also holds a Master of Science in engineering management and a Master of Science in biomedical engineering from Drexel University. More recently, Dubey completed a leadership development program from Harvard Business School Executive Education.

Posted on

Is There an Alternative to the High-Deductible Health Plan? Glad You Asked.

Is There an Alternative to the High-Deductible Health Plan? Glad You Asked.

By cutting charges for employers and decreasing or getting rid of
out-of-pocket expenses for staff members, option overall health designs are having market place share from regular coverage. The ideas say they can cut expenditures by steering associates to significant-worth companies.

For more than two decades, businesses and overall health insurers have promoted the idea that health care shoppers should have “skin in the game” by significant-deductible well being options (HDHPs).

HDHPs caught on immediately. But all that skin in the match has intended out-of-pocket costs that are so significant that several individuals skip care, suggests Brooks Deibele, business product sales chief for employee positive aspects at Holmes Murphy & Associates, an insurance policy broker in Minneapolis. In 2023, for example, anyone getting a high-deductible program on the federal marketplace that complies with Very affordable Care Act regulations could have an yearly deductible of up to $9,100. For a spouse and children, the deductible may possibly be as large as $18,200, in accordance to Health care.gov.

But now the pendulum is swinging in the other way, in accordance to Deibele. A developing quantity of employers are obtaining so-known as alternative health and fitness options, several of which do not have large deductibles and lessen or reduce copayments altogether.

“The human being generating an typical wage and facing a deductible of $5,000 or $6,000 each individual yr doesn’t use the health care procedure correctly,” claims Deibele. “Designing a strategy that gets rid of some of individuals obstacles forces people to become correct healthcare individuals.”

Also, these different health and fitness plans expense businesses 10{08cd930984ace14b54ef017cfb82c397b10f0f7d5e03e6413ad93bb8e636217f} to 15{08cd930984ace14b54ef017cfb82c397b10f0f7d5e03e6413ad93bb8e636217f} fewer in rates than standard protection, in accordance to Deibele. Any kind of health strategy that gives coverage for fewer than what traditional wellbeing insurers charge will be appealing to businesses wanting to reduced health care prices, notes Suzanne Delbanco, Ph.D., M.P.H., executive director of Catalyst for Payment Reform, a nonprofit firm in Berkeley, California, that encourages value-based mostly treatment.

One way that different well being plans preserve charges down is by working with information on the high-quality and price of healthcare that doctors and hospitals present and then introducing money incentives to steer associates to the best and most charge-efficient doctors and hospitals. Some consultants, having said that, issue regardless of whether the strategies can generate cost savings over the lengthy time period.

However in August 2022, UnitedHealthcare announced that Surest, its substitute wellness strategy featuring, was the speediest-developing plan between its self-insured businesses. Extra than 150 companies in 16 states had been enrolled in Surest strategies, in accordance to UnitedHealthcare. Surest was previously regarded as Bind. Stacy Hintermeister, MBA, senior vice president of promoting for Surest, claims the program has no deductibles or coinsurance and that out-of-pocket expenditures for personnel fall by as significantly as 44{08cd930984ace14b54ef017cfb82c397b10f0f7d5e03e6413ad93bb8e636217f}. In addition, businesses help you save 15{08cd930984ace14b54ef017cfb82c397b10f0f7d5e03e6413ad93bb8e636217f} on rates when compared with common health strategies, according to Hintermeister.

Other alternative options contain Coupe Well being LLC, which is remaining presented by Blue Cross and Blue Shield of Minnesota. Five years right after Coupe was founded in 2016, it obtained SimplePay Well being, a different alternate program, from Holmes Murphy & Associates. Gravie, a health added benefits organization in Minneapolis, has an choice program identified as Ease and comfort. And Centivo, an alternative health and fitness system administrator in Buffalo, New York, suggests it will save its employer consumers 15{08cd930984ace14b54ef017cfb82c397b10f0f7d5e03e6413ad93bb8e636217f} to 30{08cd930984ace14b54ef017cfb82c397b10f0f7d5e03e6413ad93bb8e636217f} as opposed with common wellbeing coverage. Workforce get totally free major treatment, predictable copayments and coverage without the need of a deductible, in accordance to an announcement from Morgan Overall health, a division of JPMorgan Chase & Co. Bloomberg Information noted that Morgan Overall health has invested $30 million in Centivo. JPMorgan begun Morgan Overall health in 2021 to swap Haven, the joint healthcare enterprise that JPMorgan shaped with Amazon.com Inc. and Berkshire Hathaway Inc. that shut early in 2021.

Pursuing decreased charges

It’s striking that two regular well being insurers — UnitedHealthcare and Blue Cross and Blue Shield of Minnesota — have ownership stakes in alternate health options, states Delbanco. “To me, that just displays that they are receiving fearful about the competitiveness,” she adds.

A growing proportion of insured Individuals are unable to pay for their deductibles, leaving several men and women burdened with healthcare debt, Delbanco notes. “Health insurers have been not able to maintain rates down, and there’s no correlation amongst the price ranges we pay and the top quality of care that folks get,” she suggests. “For all these motives, the common wellbeing insurance coverage product isn’t performing for a lot of people today.”

Deibele agrees, noting that common insurers are viewing the development of option overall health strategies carefully.

Distinguishing attributes

Choice well being strategies are making use of information to determine effective vendors that produce higher-quality treatment (see sidebar, “How two alternate well being options evaluate provider top quality and cost”). By linking this kind of data to monetary incentives, the ideas can steer members to far better and much more successful medical professionals and hospitals, Delbanco says.

“Twenty many years ago, I couldn’t notify you if a service provider was very low high quality, higher expense or higher excellent, lower price tag,” Delbanco notes. “But now, even if the data aren’t ideal, there are info these companies can mine to continue to keep expenses down. Then employees can choose companies that have a observe file for remaining economical and subsequent guidelines, all of which can help save a great deal of money.”

Traditional wellbeing strategies have extended made available numerous healthcare navigation and procuring capabilities to users and extended economic inducements to staff members to go to small-expense, substantial-quality medical professionals and hospitals. But these option wellbeing programs go a stage more by lowering employees’ out-of-pocket expenditures when they pick out the very best suppliers, with “best” outlined as some mix of value and quality metrics.

For illustration, prior to associates select a supplier, Surest presents the true prices members would pay out for additional than 490 health care companies. When those people members opt for large-excellent companies, additional than half get the least expensive selling price for hip substitute, reflux surgical treatment or other procedures, according to Surest. “It could experience like it is an option, but Surest is just like we shop for
all the things else,” Hintermeister notes. “Ultimately, what individuals want is a greater health and fitness strategy, better advantages, and they want to save money.”

Some alternative plans spend suppliers right, shifting that duty from personnel and conserving medical professionals and hospitals from acquiring to chase shoppers for payments. At least two option ideas present lower-charge or no-interest financial loans so that employees can make payments more than time for any costs the designs don’t address.

Expenditures disclosed upfront

By getting rid of deductibles, Coupe Wellness can inform users when they pick out vendors how substantially the plan will shell out and how considerably is their responsibility in conditions of copayments, claims Wally Gomaa, M.H.A., MBA, who co-started SimplePay Well being. For case in point, if a member needs healthcare facility treatment with a higher copayment, the member might will need to shell out a number of hundred bucks relying on the company needed, he points out. “For numerous family members, an out-of-pocket value of $400 or far more is unaffordable,” he says, adding that a no-fascination line of credit rating from Coupe Overall health enables those associates to prevent utilizing a credit card with a superior fascination fee for the copayment. For every single protected treatment, Coupe Overall health utilizes doctor and medical center general performance facts to rank companies on a few concentrations: The crimson amount is Okay yellow, improved and eco-friendly, the best.

Christopher Fanning, president of professional marketplaces for Blue Cross and Blue Protect of Minnesota, describes how these tiers have an impact on payment. “A primary care pay a visit to could price a member $10 to go to a green medical doctor, $30 for yellow, and $50 for pink,” he claims. “Once you make a selection, there is price certainty and an incentive to pick out a greater-top quality company for the reason that you will pay considerably less out of pocket.”

Employers’ general prices for Coupe Wellness are about 14{08cd930984ace14b54ef017cfb82c397b10f0f7d5e03e6413ad93bb8e636217f} lessen than what they would shell out for a conventional program, Gomaa states, and discounts for workers come out to about the exact percentage. Coupe Well being contracts with administrative company companies to shell out providers specifically for the charge of care and workers fork out their employers for their remaining share of the cost.

In addition, Coupe Wellness contracts with a financial institution to offer funding so that staff and dependents with high health care charges can distribute out payments in excess of months employing no-interest traces of credit rating, states Gomaa.

“In this model, personnel get a month to month statement of what they owe,” he explains. “They can pay the stability in full or pay it in excess of time.”

Ease and comfort, the alternate overall health system sold by Gravie, has a identical attribute. Comfort doesn’t need users to pay back for care. As an alternative, employers pay out a month to month payment for each and every employee enrolled just as employers shell out to classic health and fitness insurers. For that rate, Comfort covers, in total, all the health care companies that the ordinary human being would use every yr, says Marek Ciolko, Gravie’s co-founder and co-CEO. Gravie’s Comfort program is the first zero-deductible, zero-copay well being system, he provides.

“That usually means visits to main care or specialists, lab checks, imaging, urgent treatment and other expert services are all delivered with no out-of-pocket cost at the time of services,” he states. “Our approach design effectively insulates associates from the expense of solutions mainly because that member would access care with no copay or deductible.”

Delbanco claims she’s not absolutely sure if choice plans will have a transformative result on U.S. health care. “But,” she states, “there are quite a few, numerous companies who could be attracted to these designs due to the fact they don’t always want to go back to the times when they made use of to handle a lot of different vendors.”

Option programs may not sign the conclude of HDHPs so significantly as provide as but a different way of shelling out for and masking healthcare costs — an choice, as their name denotes, not a substitute. But they are on the primary edge of the motion towards well being prepare price transparency. For policies that get started Jan. 1 or later on, most group well being ideas have to have to disclose individualized price data to all customers for all protected treatment and providers, according to a new value-transparency rule from CMS.